127 related articles for article (PubMed ID: 18354487)
1. Dose-dependent repression of T-cell and natural killer cell genes by PU.1 enforces myeloid and B-cell identity.
Kamath MB; Houston IB; Janovski AJ; Zhu X; Gowrisankar S; Jegga AG; DeKoter RP
Leukemia; 2008 Jun; 22(6):1214-25. PubMed ID: 18354487
[TBL] [Abstract][Full Text] [Related]
2. PU.1 promotes cell cycle exit in the murine myeloid lineage associated with downregulation of E2F1.
Ziliotto R; Gruca MR; Podder S; Noel G; Ogle CK; Hess DA; DeKoter RP
Exp Hematol; 2014 Mar; 42(3):204-217.e1. PubMed ID: 24316397
[TBL] [Abstract][Full Text] [Related]
3. Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality.
Houston IB; Kamath MB; Schweitzer BL; Chlon TM; DeKoter RP
Exp Hematol; 2007 Jul; 35(7):1056-68. PubMed ID: 17588474
[TBL] [Abstract][Full Text] [Related]
4. Subversion of T lineage commitment by PU.1 in a clonal cell line system.
Dionne CJ; Tse KY; Weiss AH; Franco CB; Wiest DL; Anderson MK; Rothenberg EV
Dev Biol; 2005 Apr; 280(2):448-66. PubMed ID: 15882585
[TBL] [Abstract][Full Text] [Related]
5. PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner.
Houston IB; Huang KJ; Jennings SR; DeKoter RP
Exp Hematol; 2007 Mar; 35(3):374-384. PubMed ID: 17309818
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner.
Carotta S; Dakic A; D'Amico A; Pang SH; Greig KT; Nutt SL; Wu L
Immunity; 2010 May; 32(5):628-41. PubMed ID: 20510871
[TBL] [Abstract][Full Text] [Related]
7. Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate.
Chou ST; Khandros E; Bailey LC; Nichols KE; Vakoc CR; Yao Y; Huang Z; Crispino JD; Hardison RC; Blobel GA; Weiss MJ
Blood; 2009 Jul; 114(5):983-94. PubMed ID: 19491391
[TBL] [Abstract][Full Text] [Related]
8. Sfpi1/PU.1 mutations in mouse radiation-induced acute myeloid leukaemias affect mRNA and protein abundance and associate with disrupted transcription.
Brown NL; Finnon R; Bulman RA; Finnon P; Moody J; Bouffler SD; Badie C
Leuk Res; 2011 Jan; 35(1):126-32. PubMed ID: 20638124
[TBL] [Abstract][Full Text] [Related]
9. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
Bourette RP; Grasset MF; Mouchiroud G
Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
[TBL] [Abstract][Full Text] [Related]
10. Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells.
Colucci F; Samson SI; DeKoter RP; Lantz O; Singh H; Di Santo JP
Blood; 2001 May; 97(9):2625-32. PubMed ID: 11313251
[TBL] [Abstract][Full Text] [Related]
11. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
Huang G; Zhang P; Hirai H; Elf S; Yan X; Chen Z; Koschmieder S; Okuno Y; Dayaram T; Growney JD; Shivdasani RA; Gilliland DG; Speck NA; Nimer SD; Tenen DG
Nat Genet; 2008 Jan; 40(1):51-60. PubMed ID: 17994017
[TBL] [Abstract][Full Text] [Related]
12. Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models.
DeKoter RP; Kamath MB; Houston IB
Blood Cells Mol Dis; 2007; 39(3):316-20. PubMed ID: 17629523
[TBL] [Abstract][Full Text] [Related]
13. Visualizing PU.1 activity during hematopoiesis.
Back J; Allman D; Chan S; Kastner P
Exp Hematol; 2005 Apr; 33(4):395-402. PubMed ID: 15781329
[TBL] [Abstract][Full Text] [Related]
14. Definition of regulatory network elements for T cell development by perturbation analysis with PU.1 and GATA-3.
Anderson MK; Hernandez-Hoyos G; Dionne CJ; Arias AM; Chen D; Rothenberg EV
Dev Biol; 2002 Jun; 246(1):103-21. PubMed ID: 12027437
[TBL] [Abstract][Full Text] [Related]
15. Regulation of follicular B cell differentiation by the related E26 transformation-specific transcription factors PU.1, Spi-B, and Spi-C.
DeKoter RP; Geadah M; Khoosal S; Xu LS; Thillainadesan G; Torchia J; Chin SS; Garrett-Sinha LA
J Immunol; 2010 Dec; 185(12):7374-84. PubMed ID: 21057087
[TBL] [Abstract][Full Text] [Related]
16. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1.
Rosenbauer F; Owens BM; Yu L; Tumang JR; Steidl U; Kutok JL; Clayton LK; Wagner K; Scheller M; Iwasaki H; Liu C; Hackanson B; Akashi K; Leutz A; Rothstein TL; Plass C; Tenen DG
Nat Genet; 2006 Jan; 38(1):27-37. PubMed ID: 16311598
[TBL] [Abstract][Full Text] [Related]
17. PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45.
Anderson KL; Nelson SL; Perkin HB; Smith KA; Klemsz MJ; Torbett BE
J Biol Chem; 2001 Mar; 276(10):7637-42. PubMed ID: 11114304
[TBL] [Abstract][Full Text] [Related]
18. Role of PU.1 in hematopoiesis.
Fisher RC; Scott EW
Stem Cells; 1998; 16(1):25-37. PubMed ID: 9474745
[TBL] [Abstract][Full Text] [Related]
19. Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2.
Ikawa T; Fujimoto S; Kawamoto H; Katsura Y; Yokota Y
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5164-9. PubMed ID: 11296270
[TBL] [Abstract][Full Text] [Related]
20. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
